Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and …

FOSTER CITY, Calif. & HAYWARD, Calif.–(BUSINESS WIRE)–Jun 1, 2024–. Gilead Sciences, Inc. (Nasdaq: GILD) and Arcus Biosciences, …

Do you trust this headline?

Based on recent headline ratings, 58% of this readership currently trusts the local media, which has an average score of 84% regionally and is currently trending negative.


Media Trust Score58%